Medicinal inorganic chemistry
Author(s)
Bibliographic Information
Medicinal inorganic chemistry
(ACS symposium series, 903)
American Chemical Society, c2005
Available at 5 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
"Sponsored by the ACS divisions of Inorganic Chemistry, Inc. and Medicinal Chemistry."
Includes bibliographies and indexes
Description and Table of Contents
Description
This book, a compilation by experts in the field, is designed to provide an introduction to the area of medicinal inorganic chemistry and to summarize current, state-of-the-art developments in the field. Medicinal inorganic chemistry represents a key thrust area in medicine and biological inorganic chemistry. It is one of great current excitement and achievement. The field of metals in medicine represents an approximate $3 billion dollar a year industry, with
successes in the area of Tc- and Gd-based imaging agents and Pt-based cancer therapeutics being major contributors to this bottom line. It has become increasingly apparent, however, that metal-based pharmaceuticals can play a prominent role in areas outside of imaging and oncology, including in those
associated with the diagnosis and treatment of metabolism- and genetic disorders, cardiovascular disease, gene therapy, inflammation, reperfusion injury, stroke, diabetes, ALS, malaria, and neurological disease to name but a few. A objective of this book, therefore, is to highlight these opportunities for future advances and to foster further interactions between those working in the metal-based drug development, including imaging agents, and those engaged in the more classic pharmaceutical
industries.
Table of Contents
1.: Stephen J. Lippard: Metal Ion Chemistry for Sustaining Life
2.: John W. Kozarich: Medicinal Inorganic Chemistry: Promises and Challenges
3.: Peter C. Preusch: Metals in Medicine: Biomedical Significance and Inorganic Chemistry
4.: Christen M. Giandomenico and Ernest Wong: Discovery and Development of Third-Generation Platinum Antitumor Agents with Oral Activity
5.: John F. Schenck: Brain Iron as an Endrogenous Contrast Agent in High Field MRI
6.: Nicholas Farrell: Platinum Anticancer Drugs: From Laboratory to Clinic
7.: Jan Reedik: Mechanistic Studies of Pt and Ru Compounds with Antitumor Properties
8.: Darren J. Magda, Nikolay Gerasimchuk, Zhong Wang, Jonathan L. Sessler, and Richard A. Miller: Mechanistic Studies of Motexafin Gadolinium (Xcyrin): A Redox Active Agent That Reacts with Electron-Rich Biological Substrates
9.: Pier Lucio Anelli, Marino Brocchetta, Vito Lorusso, Giuseppe Manfredi, Alberto Morisetti, Pierfrancesco Morosini, Marcella Murru, Daniela Palano, and Massimo Visigalli: Bile Acids at Work: Development of a New Intravascular MRI Contrast Agent
10.: A. Dean Sherry, Shanrong Zhang, and Mark Woods: Water Exchange is the Key Parameter in the Design of Next-Generation MRI Agents
11.: Peter Caravan: Targeted Molecular Imaging with MRI
12.: Johannes Platzek and Heribert Schmitt-Willich: Synthesis and Development of Gadomer: A Dendritic MRI Contrast Agent
13.: Jack T. Rogers: Amyloid Precursor Protein and Ferritin Translation: Implications for Metals and Alzheimer's Disease Therapeutics
14.: George J. Brewer: Anticopper Therapy with Tetrathiomolybdate for Wilson's Disease, Cancer, and Diseases of Inflammation and Fibrosis
15.: Clare Kenny Carney, Lisa Pasierb, and David Wright: Heme Detoxification in Malaria: A Target Rich Environment
16.: Anne Robert, Francoise Benoit-Vical, and Bernard Meunier: Heme as a Trigger and Target of the Antimalarial Peroxide Artemisinin
17.: John P. Crow: Administration of Mn Polyyrin and Mn Texaphyrin at Symptom Onset Extends Survival of ALS Mice
18.: Susan R. Doctorow, Michael Baudry, Karl Huffman, Bernard Malfroy, and Simon Melov: Salen Manganese Complexes: Multifunctional Catalytic Antioxidants Protective in Models for Neurodegenerative Diseases of Aging
19.: P. John Hart and Joan Selverstone Valentine: Metal Deficient Copper-Zinc Superixide Dismutase and Familial Amyotrophic Lateral Sclerosis: Pathogenic SOD1 Oligomerization through Non-Native Protein-Protein Interactions
20.: Raymond J. Bergeron, Jan Wiegand, James S. McManis, William R. Weimar, Jeong-Hyun Park, Eileen Eiler-McManis, Jennifer Bergeron, and Gary M. Brittenham: Impact of the Lipophilicity of Desferrithiocin Anaglogues on Iron Clearance
21.: Katherine H. Thompson, Barry D. Liboiron, Graeme R. Hanson, and Chris Orvig: In Vivo Coordination Chemistry and Biocalization of Bis(ligand)oxovanadium(IV) Complexes for Diabetes Treatment
22.: Patrick J. Farmer, Daniel Brayton, Christina Moore, Donny Williams, Babbak Shahandeh, Dazhi Cen, and Frank Meyskens, Jr.: Targeting Melanoma via Metal-Based Stress
23.: Wiley J. Youngs, Claire A. Tesslier, Jared C. Garrison, Carol A. Quezada, Abdulkareem Melaiye, Semih Durmus, Matthew J. Panzer, and Aysegul Kascatan-Nebioglu: Medicinal Applications of Metal Complexes of N-Heterocyclic Carbenes
by "Nielsen BookData"